Stock Earnings

Question 1

What are Vanda Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Vanda Pharmaceuticals Inc has a total asset of $656, Net loss of $-18

Question 2

What are the key financial ratios for VNDA?

Accepted Answer

Vanda Pharmaceuticals Inc's Current ratio is 5.6, has a Net margin is -9.09, sales per share of $3.4.

Question 3

How is Vanda Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Vanda Pharmaceuticals Inc largest revenue segment is Innovative Therapies, at a revenue of 198,772,000 in the most earnings release.For geography, United States is the primary market for Vanda Pharmaceuticals Inc, at a revenue of 198,772,000.

Question 4

Is Vanda Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, Vanda Pharmaceuticals Inc has a net loss of $-18

Question 5

Does Vanda Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Vanda Pharmaceuticals Inc has liability of 117

Question 6

How many outstanding shares for Vanda Pharmaceuticals Inc?

Accepted Answer

Vanda Pharmaceuticals Inc has a total outstanding shares of 58.31

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	212	198	192	254	268	248
Revenue Growth (YoY)	12%	3%	-24%	-5%	8%	9%
Cost of Revenue	11	11	14	24	25	23
Gross Profit	200	187	177	230	243	224
Selling, General & Admin	214	146	112	136	124	140
Research & Development	100	74	76	85	55	48
Operating Expenses	321	228	191	223	181	190
Other Non Operating Income (Expenses)	13	17	20	5	0	4
Pretax Income	-107	-22	6	11	42	31
Income Tax Expense	-22	-4	3	5	9	8
Net Income	-84	-18	2	6	33	23
Net Income Growth	425%	-1,000%	-67%	-82%	43%	-80%
Shares Outstanding (Diluted)	59.09	58.14	57.55	57	56.9	55.2
Shares Change (YoY)	1%	1%	1%	0%	3%	1%
EPS (Diluted)	-1.43	-0.32	0.04	0.11	0.58	0.42
EPS Growth	407%	-844.99%	-60%	-81%	38%	-80%
Free Cash Flow	-82	-16	12	31	63	50
Free Cash Flow Per Share	-1.38	-0.27	0.2	0.54	1.1	0.9
Gross Margin	94.33%	94.44%	92.18%	90.55%	90.67%	90.32%
Operating Margin	-57.07%	-20.2%	-6.77%	2.36%	23.13%	13.7%
Profit Margin	-39.62%	-9.09%	1.04%	2.36%	12.31%	9.27%
Free Cash Flow Margin	-38.67%	-8.08%	6.25%	12.2%	23.5%	20.16%
EBITDA	-114	-32	-10	8	64	36
EBITDA Margin	-53.77%	-16.16%	-5.2%	3.14%	23.88%	14.51%
D&A For EBITDA	7	8	3	2	2	2
EBIT	-121	-40	-13	6	62	34
EBIT Margin	-57.07%	-20.2%	-6.77%	2.36%	23.13%	13.7%
Effective Tax Rate	20.56%	18.18%	50%	45.45%	21.42%	25.8%

Vanda Pharmaceuticals Inc (VNDA) Price

VNDA Stock Price Chart

VNDA Income

Follow-Up Questions